Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis
Status:
Not yet recruiting
Trial end date:
2022-06-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test safety or efficacy of study drug LY3526318 in
participants with osteoarthritis (OA) knee pain. This trial is part of the chronic pain
master protocol (H0P-MC-CPMP) which is a protocol to accelerate the development of new
treatments for chronic pain.